NXTC
NextCure, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.82
−0.26%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-351.9%
Return on equity
-189.0%
Return on assets
-267.1%
Return on invested capital
0.00x
Asset turnover
-$37.0M
Cash from operations
$4.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026